ALBEMARLE CORPORATION vs NUTRIEN LTD., two Chemicals stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where ALB and NTR diverge most: on p/e, ALB reads 389.2 and NTR reads 14.5; on revenue growth, ALB reads +19.1% and NTR reads +1.6%. The rest of the comparable metrics sit closer together. What ALB's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | ALB | NTR |
|---|---|---|
| Price | $101.19 | $67.52 |
| Market cap | $11.9B | $32.8B |
| Sector | Chemicals | Chemicals |
| Stage | Growth | Mature |
| Implied growth (priced in) | +12.1% | — |
| P/E | 389.2 | 14.5 |
| P/B | 1.13 | 1.29 |
| P/S | 2.02 | 1.22 |
| EV/EBITDA | 13.6 | 7.0 |
| Revenue growth | +19.1% | +1.6% |
| Gross margin | 33.9% | 31.1% |
| Operating margin | 26.0% | 13.9% |
| Net margin | 3.8% | 8.5% |
| Return on equity | 2.1% | 9.1% |
| Return on assets | 1.4% | 4.4% |
| Return on invested capital | 1.6% | 7.8% |
| FCF yield | 11.2% | 6.5% |
| Dividend yield | 1.6% | — |
| Debt / equity | 0.18 | 0.42 |
| Current ratio | 2.09 | 1.34 |
| Altman Z (solvency) | 7.08 | 1.89 |
| Piotroski F (quality) | 5 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.